A Decoy-Receptor-Armed Biomimetic Nanotherapeutic With Inherent Tropism for Conserved Pathogenic Macrophages for Treating Osteoarthritis and Intervertebral Disc Degeneration. [PDF]
Li F +9 more
europepmc +1 more source
Application of cerium dioxide nanoparticles in the treatment of intervertebral disc degeneration induced by oxidative stress. [PDF]
Cao R +9 more
europepmc +1 more source
Current Perspective on Orthobiology Applications for the Treatment of Intervertebral Disc Degeneration (IDD)-A Narrative Review. [PDF]
Conza G +9 more
europepmc +1 more source
Nystose treats intervertebral disc degeneration via the Nrf2 axis: a focus on oxidative stress and ferroptosis. [PDF]
Mei H, Zheng X, Han D, Xia T, Guo Y.
europepmc +1 more source
HDAC9 drives intervertebral disc degeneration by potentiating STAT1-mediated senescence and inflammation. [PDF]
Cheng X, Wang J, Chen Y, Xue R, Gao Z.
europepmc +1 more source
Integrated Multi-Omics Analysis and Experimental Validation Identify UBE2Q2 as a Candidate Molecule Target in Intervertebral Disc Degeneration. [PDF]
Cheng W +7 more
europepmc +1 more source
Ubiquitination in intervertebral disc degeneration: from mechanisms to potential therapeutic strategies. [PDF]
Liu X, Kang X.
europepmc +1 more source
Genetically Predicted Intervertebral Disc Degeneration and Risk of Osteoarthritis: A Two-Sample Mendelian Randomization Study with Mediation Analysis of Obesity and Sarcopenia. [PDF]
Zhu J, Li Z, Zhou S, Yan J, He J.
europepmc +1 more source
Biomaterial-based strategies targeting ferroptosis for alleviating intervertebral disc degeneration: Advances and perspectives. [PDF]
Fu Y +6 more
europepmc +1 more source
Proteostasis Dysfunction and Heat Shock Protein Networks in Intervertebral Disc Degeneration: Molecular Mechanisms and Therapeutic Opportunities. [PDF]
Wang Z +5 more
europepmc +1 more source

